Full-Time
Fragrance and personal-care retail chain
No salary listed
College Station, TX, USA
In Person
On-site at University Station in College Station, TX; in-person role with shifts including evenings/weekends/holidays.
See people who can refer or advise you
Bath & Body Works sells affordable fragrance and personal care products through a large network of stores and online, focusing on lotions, soaps, and home fragrances like candles. The products use recognizable scents to create an accessible luxury experience, with a emphasis on aroma and mood-enhancing properties, and include flagship lines like White Barn Candles. The brand achieves scale through mass retail presence and a strong mall footprint, distinguishing itself by its fragrance dominance, proven store format, and history as a corporate-led spin-off rather than a founder-led startup. The company aims to grow its global footprint and strengthen its digital presence to reach more customers and expand its market share.
Company Size
10,001+
Company Stage
IPO
Headquarters
Columbus, Ohio
Founded
1990
See people who can refer or advise you
Help us improve and share your feedback! Did you find this helpful?
Health Insurance
Dental Insurance
Vision Insurance
401(k) Retirement Plan
Unlimited Paid Time Off
Parental Leave
Mental Health Support
40% Discount
Natixis Advisors LLC has $7.61 million holdings in Bath & Body Works, Inc. $BBWI. June 8, 2026 Key points. * Natixis Advisors LLC increased its Bath & Body Works stake by 18.6% in the fourth quarter, buying 59,342 more shares and bringing its holdings to 378,827 shares worth about $7.61 million. * Bath & Body Works reported better-than-expected quarterly earnings of $0.32 per share on revenue of $1.38 billion, though sales were still down 3.2% year over year and the company issued full-year guidance of $2.40 to $2.65 EPS. * Wall Street remains cautious on BBWI: analysts currently have an average "Hold" rating with a consensus price target of $21.93, while the stock was trading around $17.44 and paying a quarterly dividend of $0.20 per share. * Five stocks to consider instead of Bath & Body Works. Natixis Advisors LLC increased its stake in shares of Bath & Body Works, Inc. (NYSE:BBWI - Free Report) by 18.6% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 378,827 shares of the company's stock after purchasing an additional 59,342 shares during the period. Natixis Advisors LLC owned approximately 0.19% of Bath & Body Works worth $7,607,000 as of its most recent SEC filing. Other institutional investors have also made changes to their positions in the company. Global Retirement Partners LLC acquired a new stake in shares of Bath & Body Works during the fourth quarter worth $31,000. Activest Wealth Management acquired a new stake in shares of Bath & Body Works during the fourth quarter worth $32,000. Geneos Wealth Management Inc. grew its stake in shares of Bath & Body Works by 217.7% during the first quarter. Geneos Wealth Management Inc. now owns 1,169 shares of the company's stock worth $35,000 after purchasing an additional 801 shares during the period. Danske Bank A S acquired a new stake in shares of Bath & Body Works during the third quarter worth $39,000. Finally, First Horizon Corp grew its stake in shares of Bath & Body Works by 96.3% during the fourth quarter. First Horizon Corp now owns 2,218 shares of the company's stock worth $45,000 after purchasing an additional 1,088 shares during the period. 95.14% of the stock is owned by institutional investors and hedge funds. Wall Street analysts forecast growth. A number of brokerages recently commented on BBWI. Telsey Advisory Group decreased their price objective on Bath & Body Works from $25.00 to $22.00 and set a "market perform" rating for the company in a research note on Thursday, May 28th. Raymond James Financial reiterated a "market perform" rating on shares of Bath & Body Works in a report on Wednesday, May 27th. The Goldman Sachs Group reduced their target price on Bath & Body Works from $26.00 to $23.00 and set a "neutral" rating on the stock in a report on Thursday, May 28th. Deutsche Bank Aktiengesellschaft lifted their target price on Bath & Body Works from $21.00 to $22.00 and gave the stock a "hold" rating in a report on Tuesday, March 3rd. Finally, Citigroup lowered Bath & Body Works from a "buy" rating to a "neutral" rating and lifted their target price for the stock from $21.00 to $25.00 in a report on Tuesday, February 17th. Three equities research analysts have rated the stock with a Buy rating, fourteen have issued a Hold rating and one has issued a Sell rating to the company's stock. According to data from MarketBeat.com, the company has an average rating of "Hold" and a consensus target price of $21.93. Bath & Body Works trading up 0.0%. BBWI stock opened at $17.44 on Monday. The business's 50-day moving average price is $18.58 and its two-hundred day moving average price is $20.07. The firm has a market cap of $3.51 billion, a PE ratio of 4.90, a P/E/G ratio of 1.73 and a beta of 1.42. Bath & Body Works, Inc. has a 1-year low of $14.27 and a 1-year high of $33.96. Bath & Body Works (NYSE:BBWI - Get Free Report) last released its earnings results on Wednesday, May 27th. The company reported $0.32 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.29 by $0.03. The business had revenue of $1.38 billion for the quarter, compared to analyst estimates of $1.36 billion. Bath & Body Works had a negative return on equity of 45.34% and a net margin of 10.03%.Bath & Body Works's revenue was down 3.2% on a year-over-year basis. During the same quarter in the prior year, the company posted $0.49 earnings per share. Bath & Body Works has set its Q2 2026 guidance at 0.300-0.300 EPS and its FY 2026 guidance at 2.400-2.650 EPS. On average, analysts forecast that Bath & Body Works, Inc. will post 2.62 earnings per share for the current year. Bath & Body Works dividend announcement. The firm also recently declared a quarterly dividend, which will be paid on Friday, June 19th. Shareholders of record on Friday, June 5th will be given a dividend of $0.20 per share. This represents a $0.80 dividend on an annualized basis and a yield of 4.6%. The ex-dividend date of this dividend is Friday, June 5th. Bath & Body Works's payout ratio is 22.47%. Bath & Body Works profile. Bath & Body Works, Inc is a leading specialty retailer focused on personal care, home fragrance and complementary products. Through its flagship Bath & Body Works brand, the company offers a diverse assortment of shower gels, lotions, fragrance mists, candles and home fragrance items. Its product portfolio also includes the White Barn Candle Co range of premium scented candles and diffusers. Bath & Body Works serves consumers through a combination of brick-and-mortar stores and e-commerce platforms, delivering seasonal collections, limited-edition releases and signature scent lines. Founded in 1990 as part of Limited Brands (now L Brands), Bath & Body Works opened its first store in New Albany, Ohio, and quickly expanded across the United States. Want to see what other hedge funds are holding BBWI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Bath & Body Works, Inc. (NYSE:BBWI - Free Report). This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to [email protected]. Before you consider Bath & Body Works, you'll want to hear this. MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Bath & Body Works wasn't on the list. While Bath & Body Works currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
Bath & Body Works will pay a dividend of $0.20 per share on 19 June to shareholders on record before the 5 June ex-dividend date. The company distributed $0.80 per share over the past year, representing a 4.0% trailing yield based on the current share price of $20.02. The retailer paid out just 23% of its profit and 18% of its free cash flow last year, suggesting the dividend is sustainable with a comfortable margin of safety. Earnings per share have grown 3.0% annually over the past five years. With over 75% of earnings retained in the business, Bath & Body Works has room to either reinvest in growth or increase its payout ratio whilst maintaining dividend coverage.
Bath & Body Works shares surged 9.7% to $19.45 after reporting first-quarter results that exceeded expectations. The company's net income rose 74% to $183 million from $105 million year-on-year, whilst net sales declined 3% to $1.378 billion, beating earlier guidance of a 4-6% decline. CEO Daniel Heaf acknowledged the performance exceeded expectations but remained "below the standard our brand is capable of delivering". The company expects improvements to build through 2026 and more significantly into 2027. For the second quarter, Bath & Body Works forecasts net sales to decline 3-5% from $1.549 billion in Q2 2025. Separately, finance chief Eva Boratto will step down on 12 June to join Cencora, with Tom Javitch serving as interim replacement.
Bath & Body Works has appointed company veteran Tom Javitch as interim CFO effective 12 June, following the departure of Eva Boratto, who is leaving to become CFO at pharmaceutical company Cencora. The company has begun searching for a permanent successor. Javitch has spent 25 years across Limited Brands and its legacy organisations, including 16 years at Bath & Body Works in various roles. He most recently served as executive vice president of brand finance. Boratto is departing after approximately two years as CFO, having joined the Columbus, Ohio-based retailer in 2023 from CVS Health. The appointment comes as the company works to modernise its brand amid slumping sales, with first-quarter net sales falling 3% year-over-year to $1.4 billion.
Bath & Body Works reported first-quarter earnings that exceeded Wall Street expectations, with adjusted earnings per share of $0.32 beating forecasts of $0.29. Revenue reached $1.4 billion, surpassing consensus estimates of $1.36 billion, though sales declined 3% year-over-year. Shares initially jumped 15% in premarket trading before settling to gains of approximately 4.4%. Chief executive Daniel Heaf said the results "exceeded guidance" and noted the company's brand refresh strategy is "beginning to resonate with consumers." For the second quarter, the company projected earnings of $0.20 to $0.25 per share and expects sales to decline 3% to 5%. Bath & Body Works maintained its full-year adjusted earnings outlook of $2.40 to $2.65 per share. The retailer also announced chief financial officer Eva Boratto will step down on 12 June, with Tom Javitch named interim CFO.